- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 17.35M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 21.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 5.13M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $207.87K |
| Capex | Q1 2026 · Mar 31, 2025 | $170.07K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.29M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.9M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $6.8M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $7.01M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $20.83M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $30.62M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $20.14M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $19.92M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $22.66M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $22.44M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $22.83M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $23.5M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $41.75M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $51.32M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.47 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.05 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.47 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.05 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $376.43K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $309.96K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$10.12M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.4M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$6.43M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.1M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.11M |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.37M |